Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC281

pegvalíasi (Palynziq)

  • Status:
    Veitt
  • Application date:
    18.10.2019
  • Application published:
    15.11.2019
  • Grant published:
    15.6.2021
  • Max expiry date:
    22.5.2033
  • Medicine name:
    Palynziq
  • Medicine for children:
    No

Timeline

Today
18.10.2019Application
15.11.2019Publication
15.6.2021Registration
22.5.2033Expires

Marketing license

  • IS authorization number:
    EU/1/19/1362/001; EU/1/19/1362/002; EU/1/19/1362/003-004
  • Date:
    4.6.2019
  • Foreign authorization number:
    EU/1/19/1362
  • Date:
    3.5.2019

Owner

  • Name:
    BioMarin Pharmaceutical Inc.
  • Address:
    105 Digital Drive, Novato US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 19.05.2021

Upload documents